Amgen plans to acquire deCODE Genetics for $415 mln

By Admin
Amgen plans to buy a gene-hunting company deCODE Genetics for $415 million. The gene-hunting company is based in Iceland and is known for discoveries l...

Amgen plans to buy a gene-hunting company deCODE Genetics for $415 million. The gene-hunting company is based in Iceland and is known for discoveries like finding that the genetic nature of human disease was far more complex than thought.

The two companies hopes that the deal will be symbolic, as deCODE gets a well-financed partner, and Amgen capitalizes on the new research brought on by the gene-hunting business.

DeCODE  studied the local population in Iceland to identify genetic variations linked to schizophrenia, cancer and other diseases. 

The company has also published a study that identifies a rare mutation that protects people from getting the Alzheimer’s disease. DeCODE had trouble to build a sustainable business and filed for bankruptcy back in 2009. The company was brought out of bankruptcy in 2010 by Saga Investments.

Amgen is the world’s independent biotechnology company that said it can use deCODE’s finding and technology to its advantage.  “This is a magical moment when it comes to the possibility of utilizing genetics,”

Kari Stefansson, Amgen’s chief executive officer said, He also said, “I have been dreaming of a moment when we can have an impact on health care through genetics.”

The transaction doesn’t require regulatory approval, and is expected to be completed by the end of the year. Amgen acquired Micromet Inc earlier this year for $1.16 billion, helping it to add an experimental leukemia drug to its repertoire.

Amgen is a multinational biopharmaceutical company that discovers, develops and manufactures and delivers innovative human therapeutics. deCODE Genetics is a global leader in analyzing and understanding the human genome.

Share
Share

Featured Articles

Cardinal Health’s clinically integrated pharma supply chain

Peter Siavelis, SVP & General Manager, Health System and Provider Distribution & Services at Cardinal Health, discusses the integrated pharma supply chain

Healthcare Digital news roundup: digital healthcare & AI

This week in Healthcare Digital, we looked at digital skills for healthcare leaders, medical technology & acoustic AI used in digital cough monitoring

Hospitals must embrace IoMT device security

As cybersecurity threats rise in the healthcare sector, hospitals must get serious about IoMT device protection, says Shankar Somasundaram, CEO of Asimily

Mental health support for working women and mothers

Digital Healthcare

Digital evolution delivers better healthcare outcomes

Digital Healthcare

Hyfe AI uses acoustic AI in its digital cough monitoring

Technology & AI